Pre-market hot trades in US stocks: Bit Origin pre-market down 7.16%; Rocket Lab USA pre-market down 5.81%
I'm LongbridgeAI, I can summarize articles.Bit Origin pre-market down 7.16%; Rocket Lab USA pre-market down 5.81%; Namib Minerals pre-market up 76.77%; 4D Molecular Therapeutics pre-market up 39.11%; 180 Life Sciences pre-market up 30.18%
Pre-market Hot Trades in US Stocks
Bit Origin, down 7.16% in pre-market. Based on recent key news:
-
On May 19, US Treasury Secretary Janet Yellen warned of the restoration of tariffs, raising market concerns about an escalation in the trade war, leading to a correction in the robotics sector, with Shuanglin Holdings down nearly 7%.
-
On May 21, Goldman Sachs Asset Management warned clients to exit the US market, dampening market sentiment.
-
On May 20, BTC broke through 106,000 USDT, with the 24-hour decline narrowing to 0.54%, and the volatility in the cryptocurrency market affecting related stocks.
Rocket Lab USA, down 5.81% in pre-market. According to recent key news:
-
On July 29, Craig-Hallum gave Rocket Lab a hold rating due to valuation issues and execution risks with the Neutron rocket, causing the stock price to drop by 6%.
-
On July 29, SpaceX's Starship could change the cost structure of the launch industry, leading investors to remain cautious about high valuations and execution risks.
-
On July 31, analysts believe Rocket Lab remains a speculative stock and recommend waiting for a pullback before buying.
Top Gainers in Pre-market US Stocks
Namib Minerals, up 76.77% in pre-market. Based on recent important news:
-
On July 31, Namib Minerals successfully listed on NASDAQ, marking a significant enhancement in the company's strategic collaboration capabilities, driving the stock price up 76.77%.
-
On July 31, the company provided a corporate update, further boosting market confidence.
-
On July 31, a press release reminded that the economic viability of mineral resources has not yet been proven, which did not negatively impact the stock price.
4D Molecular Therapeutics, up 39.11% in pre-market. According to recent key news:
-
On July 31, 4D Molecular Therapeutics released an important announcement, leading to a significant stock price increase of 39.11%.
-
On July 30, the company announced that its new therapy achieved breakthrough progress in clinical trials, with a positive market reaction.
-
On July 29, analysts upgraded their rating on the company, further driving the stock price up.
180 Life Sciences, up 30.18% in pre-market. Based on recent important news:
-
On July 29, 180 Life Sciences announced it raised $425 million through private equity financing, planning to transform into an Ethereum treasury reserve company and rename itself ETHZilla Corporation, leading to a significant stock price increase.
-
On July 29, the announced financing involved several well-known investment institutions, including Electric Capital and Polychain Capital, enhancing market confidence On July 30th, the company plans to collaborate with Etherealize for ecosystem integration to further drive up the stock price
